Double-blind trials conducted in the early 1980s showed that subcutane
ous injections of salmon calcitonin in patients suffering from mania r
esulted in significant decreases in irritability, euphoria and hyperac
tivity. Although these results were promising, there were no follow-up
studies in this area. A MEDLINE search into the effect of calcitonin
on neuronal tissues revealed that calcitonin affects neuronal tissues
in a manner similar to that of the currently accepted mood-stabilizing
agents - namely by modulating intracellular second messenger signalli
ng mechanisms, stabilizing neuronal membranes and inhibiting neuronal
calcium influx We suggest that these effects of calcitonin on neuronal
tissues, combined with earlier clinical research showing its efficacy
in treating the acute symptoms of mania, make calcitonin a candidate
for further research in the treatment of bipolar disorder.